FDA 483 - Dolan Central Illinois Compounding LLC dba Preckshot Professional Pharmacy - August 10, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
This FDA Form 483 was issued to Dolan Central Illinois Compounding LLC dba Preckshot Professional Pharmacy, located at 5832 N Knoxville Ave, Ste E, Peoria, IL 61614-4300, a producer of sterile and non-sterile drug products. The inspection, conducted from July 30, 2018, to August 10, 2018, identified five observations.
Observation 1 noted that the facility's design and/or operation permitted poor material flow, specifically, materials were brought into the ISO 7 Buffer room directly from an unclassified area via a b(4) for sterile processing supplies.
Observation 2 detailed that non-sterile bulk solutions were held for extended periods without supporting documentation for hold time. For example, Alprostadil stock solution, lot 07122018@9, was produced in an uncertified hood and stored for up to b(4) days without b(4) prior to b(4) after use, and was used in multiple sterile product lots.
Observation 3 stated that the firm prepared multi-dose sterile drug products without preservatives, but with extended beyond-use dates. Examples included Acetylcysteine Ophthalmic solutions (45 days frozen/refrigerated) and Tacrolimus in Corn Oil NF Ophthalmic solutions (28 days room temperature).
Observation 4
- Inspection Date
- August 10, 2018
- Office
- Chicago District Office
- Person
ID · 8fa6d0fa-7610-405f-a513-d5201a315364
Full citation text and observation details available on the Dashboard.